Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú

Jose Matta-Chuquisapon, Esther Valencia-Bazalar, Carlos Sevilla-Andrade, Helí Jaime Barrón-Pastor , .

Keywords: Escherichia coli, phylogeny, beta-lactam resistance, ciprofloxacin, gentamicins

Abstract

Introduction: Healthcare-associated infections are a public health problem due to the increased morbimortality of patients, especially those with risk factors such as immunosuppression due to oncological diseases. It is essential to determine the genetic diversity of the main microorganisms causing healthcare infections by combining traditional epidemiological surveillance and molecular epidemiology for better outbreak follow-up and early detection.
Objective: To determine the phylogenetic group and antibiotic resistance of Escherichia coli isolated from hospitalized oncologic patients.
Materials and methods: We conducted a cross-sectional study of 67 strains of ESBL-producing Escherichia coli to determine their phylogenetic group and described their antibiotic resistance profile, beta-lactam resistance genes, as well as the type of sample and the hospitalization areas from which they were recovered.
Results: The most frequent phylogenetic group was B2 (36%); 57% of B2 strains were isolated from urine and 33% came from the urology department. Resistance to ciprofloxacin and gentamicin was 92% and 53%, respectively, and 79% of the strains had the blaCTX-M gene. A significant association (p<0.05) was found between the phylogenetic groups, ciprofloxacin resistance, and the age of the patients.
Conclusion: The predominant E. coli phylogroup was B2. We evidenced high resistance to ciprofloxacin and gentamicin, a high proportion of ESBL strains with the blaCTX-M gene, and a significant association between the phylogenetic group and the resistance to ciprofloxacin.

Downloads

Download data is not yet available.
  • Jose Matta-Chuquisapon Grupo de Investigación Resistencia a los Antimicrobianos, Universidad Nacional Mayor de San Marcos, Lima, Perú http://orcid.org/0000-0001-5132-4839
  • Esther Valencia-Bazalar Grupo de Investigación Resistencia a los Antimicrobianos, Universidad Nacional Mayor de San Marcos, Lima, Perú https://orcid.org/0000-0002-4059-9842
  • Carlos Sevilla-Andrade Grupo de Investigación Resistencia a los Antimicrobianos, Universidad Nacional Mayor de San Marcos, Lima, Perú; Centro de Investigaciones Tecnológicas, Biomédicas y Medioambientales, Universidad Nacional Mayor de San Marcos, Lima, Perú https://orcid.org/0000-0001-9938-9922
  • Helí Jaime Barrón-Pastor Grupo de Investigación Resistencia a los Antimicrobianos, Universidad Nacional Mayor de San Marcos, Lima, Perú; Centro de Investigación de Bioquímica y Nutrición “Alberto Guzmán Barrón”, Universidad Nacional Mayor de San Marcos, Lima, Perú https://orcid.org/0000-0002-4041-4406

References

Organización Panamericana de la Salud. Vigilancia epidemiológica de las infecciones asociadas a la atención de la salud en neonatología. Módulo IV - PAHO; 2013. Fecha de consulta: 18 de febrero de 2022. Disponible en: https://iris.paho.org/handle/10665.2/31361

Yagui-Moscoso M, Vidal-Anzardo M, Rojas-Mezarina L, Sanabria-Rojas H. Prevención de infecciones asociadas a la atención de salud: conocimientos y prácticas en médicos residentes. An Fac Med. 2021;82:131-9. https://doi.org/10.15381/anales.v82i2.19839

Johnson JR, Russo TA. Molecular epidemiology of extraintestinal pathogenic Escherichia coli. EcoSal Plus. 2018;8:1-32. https://doi.org/10.1128/ecosalplus.ESP-0004-2017

Bonilla-Marciales AP, Chávez-Cañas WO, Hernández-Mogollón RA, Ramón-Jaimes NA. Estrategias de prevención y control de las infecciones en pacientes oncológicos. MedUNAB. 2019;22:356-68.

Velázquez-Brizuela IE, Aranda-Gama J, Camacho-Cortés JL, Ortiz GG. Epidemiología de infecciones nosocomiales en el Instituto Jalisciense de Cancerología. Rev Cuba Salud Pública. 2013;39:19-31.

Clermont O, Christenson JK, Denamur E, Gordon DM. The Clermont Escherichia coli phylo-typing method revisited: Improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5:58-65. https://doi.org/10.1111/1758-2229.12019

Gonzáles-Rodríguez AO, Pastor HJ, Villafuerte CA, Barrón YL de, Miranda DV de, Cunza SS. Clasificación filogenética de Escherichia coli uropatógena y respuesta inmunometabólica en adultos mayores con infección urinaria en casas de reposo. Arch Med Col. 2019;19:238-46. https://doi.org/10.30554/archmed.19.2.3334.2019

Nicolas-Chanoine MH, Bertrand X, Madec JY. Escherichia coli ST131, an intriguing clonal group. Clin Microbiol Rev. 2014;27:543-74. https://doi.org/10.1128/CMR.00125-13

CLSI. M100Ed27 - Performance standards for antimicrobial susceptibility testing. 32nd edition. Fecha de consulta: 21 de febrero de 2022. Disponible en: https://clsi.org/standards/products/microbiology/documents/m100/

Ghasemi Y, Archin T, Kargar M, Mohkam M. A simple multiplex PCR for assessing prevalence of extended-spectrum β-lactamases producing Klebsiella pneumoniae in Intensive Care Units of a referral hospital in Shiraz, Iran. Asian Pac J Trop Med. 2013;6:703-8. https://doi.org/10.1016/S1995-7645(13)60122-4

Chávez-Hidalgo DC. Frecuencia y subtipos del gen blaCTX-M en enterobacterias productoras de BLEE aisladas de urocultivos en el Instituto Nacional de Enfermedades Neoplásicas de enero a diciembre del 2017 [tesis]. Lima: Universidad Nacional Mayor San Marcos; 2019.

Tejada-Llacsa PJ, Huarcaya JM, Melgarejo GC, Gonzáles LF, Cahuana J, Pari RM, et al. Caracterización de infecciones por bacterias productoras de BLEE en un hospital de referencia nacional. An Fac Med. 2015;76:161-6. https://doi.org/10.15381/anales.v76i2.11143

Sader HS, Jones RN, Andrade-Baiocchi S, Biedenbach DJ, SENTRY Participants Group (Latin America). Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Diagn Microbiol Infect Dis. 2002;44:273-80. https://doi.org/10.1016/s0732-8893(02)00469-8

Koirala S, Khadka S, Sapkota S, Sharma S, Khanal S, Thapa A, et al. Prevalence of CTX-M β-lactamases producing multidrug resistant Escherichia coli and Klebsiella pneumoniae among patients attending Bir Hospital, Nepal. BioMed Res Int. 2021:9958294. https://doi.org/10.1155/2021/9958294

Dirar MH, Bilal NE, Ibrahim ME, Hamid ME. Prevalence of extended-spectrum β-lactamase (ESBL) and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Enterobacteriaceae isolates from patients in Khartoum, Sudan. Pan Afr Med J. 2020;37:213. https://doi.org/10.11604/pamj.2020.37.213.24988

Demirci M, Ünlü Ö, İstanbullu Tosun A. Detection of O25b-ST131 clone, CTX-M-1 and CTX-M-15 genes via real-time PCR in Escherichia coli strains in patients with UTIs obtained from a university hospital in Istanbul. J Infect Public Health. 2019;12:640-4. https://doi.org/10.1016/j.jiph.2019.02.017

Hernández E, Araque M, Millán Y, Millán B. Prevalencia de b-lactamasa CTX-M-15 en grupos filogenéticos de Escherichia coli uropatógena aisladas en pacientes de la comunidad en Mérida, Venezuela. Invest Clin. 2014;55:13.

Galindo-Méndez M. Caracterización molecular y patrón de susceptibilidad antimicrobiana de Escherichia coli productora de β-lactamasas de espectro extendido en infección del tracto urinario adquirida en la comunidad. Rev Chil Infectol. 2018;35:29-35. https://doi.org/10.4067/s0716-10182018000100029

Gonzáles E, Patiño L, Ore E, Martínez V, Moreno S, Cruzado NB, et al. β-lactamasas de espectro extendido tipo CTX-M en aislamientos clínicos de Escherichia coli y Klebsiella pneumoniae en el Instituto Nacional de Salud del Niño-Breña, Lima, Perú. Rev Médica Hered. 2019;30:242-8. https://doi.org/10.20453/rmh.v30i4.3659

Alsharapy SA, Yanat B, Lopez-Cerero L, Nasher SS, Díaz-De-Alba P, Pascual Á, et al. Prevalence of ST131 clone producing both ESBL CTX-M-15 and AAC(6’)Ib-cr among ciprofloxacin-resistant Escherichia coli isolates from Yemen. Microb Drug Resist Larchmt N. 2018;24:1537-42. https://doi.org/10.1089/mdr.2018.0024

Millán Y, Araque M, Ramírez A. Distribución de grupos filogenéticos, factores de virulencia y susceptibilidad antimicrobiana en cepas de Escherichia coli uropatógena. Rev Chil Infectol. 2020;37:117-23. https://doi.org/10.4067/s0716-10182020000200117

Cole BK, Ilikj M, McCloskey CB, Chávez-Bueno S. Antibiotic resistance and molecular characterization of bacteremia Escherichia coli isolates from newborns in the United States. PLoS ONE. 2019;14:e0219352. https://doi.org/10.1371/journal.pone.0219352

Ranjbar R, Nazari S, Farahani O. Phylogenetic analysis and antimicrobial resistance profiles of Escherichia coli strains isolated from UTI-suspected patients. Iran J Public Health. 2020;49:1743-9. https://doi.org/10.18502/ijph.v49i9.4094

Tenaillon O, Skurnik D, Picard B, Denamur E. The population genetics of commensal Escherichia coli. Nat Rev Microbiol. 2010;8:207-17. https://doi.org/10.1038/nrmicro2298

Tsai W-L, Hung C-H, Chen H-A, Wang J-L, Huang I-F, Chiou Y-H, et al. Extended-spectrum β-lactamase-producing Escherichia coli bacteremia: Comparison of pediatric and adult populations. J Microbiol Immunol Infect. 2018;51:723-31. https://doi.org/10.1016/j.jmii.2017.08.005

How to Cite
1.
Matta-Chuquisapon J, Valencia-Bazalar E, Sevilla-Andrade C, Barrón-Pastor HJ. Phylogeny and antimicrobial resistance of extended-spectrum beta-lactamaseproducing Escherichia coli from hospitalized oncology patients in Perú. biomedica [Internet]. 2022 Sep. 2 [cited 2024 May 19];42(3):470-8. Available from: https://revistabiomedica.org/index.php/biomedica/article/view/6263

Some similar items:

Published
2022-09-02
Section
Original articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code